Oscar Haffen Lamm's questions to Valneva SE (VALN) leadership • Q1 2025
Question
Oscar Haffen Lamm of Bryan Garnier & Co. asked about potential seasonality in IXIARO sales, the growth forecast for the asset for the rest of the year, and whether the updated French recommendation for IXCHIQ could impact the order for the La Réunion outbreak.
Answer
CFO Peter Buhler explained there was no significant seasonality for IXIARO in Q1, though some stocking occurred in an indirect market. He reiterated the expectation for double-digit CAGR for IXIARO for the full year. CEO Thomas Lingelbach confirmed that the 40,000-dose order for La Réunion has been delivered.